23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.

23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.

Scope of the Report:
North America is the largest supplier and consumption market of 23-Valent Pneumococcal Polysaccharide Vaccine, with a production market share nearly 70% and sales market share nearly 28% in 2015. Because Sanofipasteur, a competitor from Europe, transferred its vaccine type gradually, the production market share of North America in the world has enjoyed a dramatic increase.
The second place is EU, following North America with production market share of 15% and sales market share nearly 20% in 2015.China is another important market of 23-Valent Pneumococcal Polysaccharide Vaccine, enjoying 10% production market share and 15% sales market share in 2015.
The worldwide market for 23-Valent Pneumococcal Polysaccharide Vaccine is expected to grow at a CAGR of roughly 16.3% over the next five years, will reach 3830 million US$ in 2024, from 1550 million US$ in 2019, according to a new WMR study.
This report focuses on the 23-Valent Pneumococcal Polysaccharide Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
MSD
Sanofipasteur
CDIBP

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Single Dose Vial
Pre-filled Syringe

Market Segment by Applications, can be divided into
For Children (2-10)
For Person (10-64)
For The Old (≥65)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 23-Valent Pneumococcal Polysaccharide Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, with price, sales, revenue and global market share of 23-Valent Pneumococcal Polysaccharide Vaccine in 2017 and 2018.
Chapter 3, the 23-Valent Pneumococcal Polysaccharide Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 23-Valent Pneumococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, 23-Valent Pneumococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe 23-Valent Pneumococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Single Dose Vial
1.2.2 Pre-filled Syringe
1.3 Market Analysis by Applications
1.3.1 For Children (2-10)
1.3.2 For Person (10-64)
1.3.3 For The Old (≥65)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 MSD
2.1.1 Business Overview
2.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofipasteur
2.2.1 Business Overview
2.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 CDIBP
2.3.1 Business Overview
2.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis by Regions
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
4.5 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
5 North America 23-Valent Pneumococcal Polysaccharide Vaccine by Country
5.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
6 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
6.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
6.3 UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
6.4 France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine by Country
7.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
7.5 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
8 South America 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Countries
9.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
10 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Type
10.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Single Dose Vial Sales Growth and Price
10.2.1 Global Single Dose Vial Sales Growth (2014-2019)
10.2.2 Global Single Dose Vial Price (2014-2019)
10.3 Pre-filled Syringe Sales Growth and Price
10.3.1 Global Pre-filled Syringe Sales Growth (2014-2019)
10.3.2 Global Pre-filled Syringe Price (2014-2019)
11 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Application
11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2014-2019)
11.2 For Children (2-10) Sales Growth (2014-2019)
11.3 For Person (10-64) Sales Growth (2014-2019)
11.4 For The Old (≥65) Sales Growth (2014-2019)
12 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
12.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
12.2.4 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
12.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2019-2024)
12.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure 23-Valent Pneumococcal Polysaccharide Vaccine Picture
Table Product Specifications of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Global Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Types in 2018
Table 23-Valent Pneumococcal Polysaccharide Vaccine Types for Major Manufacturers
Figure Single Dose Vial Picture
Figure Pre-filled Syringe Picture
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Applications in 2018
Figure For Children (2-10) Picture
Figure For Person (10-64) Picture
Figure For The Old (≥65) Picture
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2014-2024)
Table MSD Basic Information, Manufacturing Base and Competitors
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Type and Applications
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Type and Applications
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CDIBP Basic Information, Manufacturing Base and Competitors
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Type and Applications
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2017-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer in 2017
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer in 2018
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2017-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2017
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2018
Figure Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2014-2019)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Regions (2014-2019)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2014-2019)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Regions (2014-2019)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2014
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2018
Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2014-2019)
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2014-2019)
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2014-2019)
Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2014
Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2018
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2014-2019)
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2014
Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2018
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2014-2019)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2014-2019)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2014-2019)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2014-2019)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2017
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2018
Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2014-2019)
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries 2018
Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2014-2019)
Figure Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries 2018
Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2014-2019)
Table South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2014-2019)
Table South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2014-2019)
Figure South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2018
Table South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2014-2019)
Table South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2014-2019)
Figure South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2018
Figure Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2014-2019)
Table Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2018
Table Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2014-2019)
Table Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2014
Figure Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2018
Figure Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure UAE 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2014-2019)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2014-2019)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2014-2019)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2014-2019)
Figure Global Single Dose Vial Sales Growth (2014-2019)
Figure Global Single Dose Vial Price (2014-2019)
Figure Global Pre-filled Syringe Sales Growth (2014-2019)
Figure Global Pre-filled Syringe Price (2014-2019)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2014-2019)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2014-2019)
Figure Global For Person (10-64) Sales Growth (2014-2019)
Figure Global For The Old (≥65) Sales Growth (2014-2019)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate (2019-2024)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Regions (2019-2024)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Regions (2019-2024)
Figure North America Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
Figure Europe Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
Figure Asia-Pacific Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
Figure South America Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
Figure Middle East and Africa Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2019-2024)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2019-2024)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2019-2024)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

Global Cold Chain Equipment Market (2024 Edition): Analysis By Equipment Type (Refrigerators, Deep Freezers & Reefer Containers, Cold Boxes & Vaccine Carriers, Cold Rooms/ Chillers, Other Equipment Types), By Purpose, By End-use, By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...

Global Vaccine Supply Chain Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Vaccine Supply Chain Solutions Market: The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...

Global Digital Vaccine Tracking System Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Digital Vaccine Tracking System Market: The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity...

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...

2023-2028 Global and Regional Whole Cell Cholera Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

2023-2028 Global and Regional Viral Vaccine Media Industry Status and Prospects Professional Market Research Report Standard Version...

The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...

2023-2028 Global and Regional Vero Cell Rabies Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Vero Cell Rabies Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...